Life Sciences Organizations Choose Oracle to Accelerate and Simplify Clinical Trial Data Collection
Posted on: Wednesday, 21 January 2009, 07:00 CST
REDWOOD SHORES, Calif., Jan. 21 /PRNewswire-FirstCall/ -- News Facts-- Organizations spanning the life sciences industry -- including biopharmaceutical companies, contract research organizations (CROs) and pharmaceutical manufacturers -- are increasingly turning to Oracle(R) Remote Data Capture (RDC) 4.5.3 (http://www.oracle.com/industries/life_sciences/remote-data-capture.html)to conduct trials more efficiently and effectively.
-- Boehringer Ingelheim (http://www.boehringer-ingelheim.com/corporate/home/home.asp), Bristol-Myers Squibb (http://www.bms.com/landing/data/index.html), ICON (http://www.iconclinical.com/), LEO Pharma (http://www.leo-pharma.com/w-site/leo/docs.nsf), PPD (http://www.ppdi.com/) and Quintiles Transnational (http://www.quintiles.com/) are among a rapidly growing group of customers using Oracle RDC 4.5.3 to help increase efficiency in clinical trials data collection, improve data quality and enhance decision making.-- Oracle RDC 4.5.3, the latest release of Oracle's best-in-class electronic data capture (EDC) offering, is completely Web-based -- with zero client footprint for the HTML data entry window -- which enables improved global access and performance.
-- This enables life sciences organizations to conduct global clinical studies more cost effectively using paper, electronic data capture, or hybrid methods.
-- The Oracle EDC application helps meet the needs of trial sponsors as well as investigative site personnel by providing a simplified user interface and eliminating site software installation. This helps to increase staff efficiency by allowing investigators to quickly locate patient visits and case report forms (CRFs).
-- Oracle RDC 4.5.3 is integrated with Oracle Clinical (http://www.oracle.com/industries/life_sciences/oracle-clinical.html), the industry's leading clinical data management system, and is an integral component of Oracle's extensive suite of clinical trial management applications.
Supporting Quotes
-- "As one of the largest users of Oracle Remote Data Capture 4.5.3, PPD
is providing clients with the robustness and flexibility this system offers.
We have realized greater efficiencies since implementing Oracle RDC 4.5.3,
including reduced study timelines, real-time decision making and ease of use
for investigator sites," said
-- "As a global clinical research organization, we manage clinical trials
for the world's top 20 pharmaceutical organizations and leading biotechnology
companies. Oracle Remote Data Capture 4.5.3 helps us to accelerate the capture
of subject data and offers a robust system of edit checks to ensure the data
accuracy and integrity essential to effectively managing global mega trials,"
said
-- "Quintiles Transnational is committed to enhancing clinical trial
efficiency for its biotech and pharmaceutical clients worldwide. We looked to
Oracle Remote Data Capture to help us rationalize and accelerate the clinical
trial process through automated data collection, and more rapid data
processing and reporting," said
-- "Life sciences organizations increasingly require software applications
that will help them automate and effectively manage the clinical phase from
study setup through submission. Oracle's comprehensive suite of applications
for clinical development provides an integrated system for managing large
volumes of patient data, as well as sophisticated tracking, analysis and
reporting capabilities. Today, hundreds of life sciences organizations are
harnessing the power of Oracle's clinical solutions to accelerate insights for
better health," said
Supporting Resources
-- Oracle Remote Data Capture Data Sheet (http://www.oracle.com/industries/life_sciences/rdc-onsite-datasheet.pdf)-- Oracle Remote Data Capture 4.5.3 News Release (http://www.oracle.com/corporate/press/2008_feb/remotedatacapture.html)
-- Oracle in Health Sciences (http://www.oracle.com/industries/health_sciences/index.html)-- Oracle Announces Creation of Health Sciences Global Business Unit (http://www.oracle.com/us/corporate/press/015803_EN?rssid=rss_ocom_pr)
About Oracle
Oracle (Nasdaq: ORCL) is the world's largest enterprise software company. For more information about Oracle, please visit our Web site at http://www.oracle.com.
Trademarks
Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020718/ORCLLOGO)
SOURCE Oracle
Source: PR Newswire
Related Articles
- Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities
- Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry
- Oracle(R) E-Business Suite Release 12.1 Now Available to Help Organizations Achieve Better Business Value with New Products and Functionality
- Dell and EMC Combine Next-Generation Technology to Maximize and Simplify Oracle Data Warehouse Environments
- Celebrating and Recognizing Excellence in Indiana's Life Sciences, BioCrossroads Establishes the Life Sciences Champion of the Year Award
- Soliant Health to Exhibit at Association of Clinical Research Professionals Global Conference & Exhibition
- Boston Scientific Announces Additions to Clinical Sciences Organization
- ImClone Systems to Host Investor Reception on June 5, 2007 Following a Clinical Science Symposium Session About EGFR As a Therapeutic Target in GI Malignancy
- Graybar Selects MegaPath to Provide Broadband Virtual Private Network (VPN) Services; $1.25 Million Agreement Includes Global Remote Access Services (GRAS)
- Oracle(R) Fusion Middleware Generates Unprecedented Global Partner Support
User Comments (0)

RSS Feeds